NICE recommends first long-acting injectable for HIV
The National Institute for Health and Care Excellence (NICE) has published a positive Final Appraisal Document (FAD) recommending Vocabria (cabotegravir long-acting injection) in combination with...
NHS strikes new agreements to expand life-saving blood thinning drugs
NHS Chief Executive Amanda Pritchard has announced that more than 20,000 strokes and 5,000 deaths could be averted after NHS England struck new agreements...
NICE recommendation for cenobamate as treatment for adult epilepsy
The National Institute for Health and Clinical Excellence (NICE) has issued a Final Appraisal Determination (FAD) for Cenobamate▼ (ONTOZRY®). The published FAD recommends cenobamate as an...
JCVI updates its COVID-19 booster vaccination guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has updated its guidance and is now advising that all adults aged 40 to 49 should...
Gilead Sciences appoints Véronique Walsh as General Manager of UK and Ireland operations
Gilead Sciences has announced the appointment of Véronique Walsh as General Manager of its UK and Ireland operations, managing a portfolio of products spanning...
EC approves Valneva deal for COVID-19 vaccine
The European Commission (EC) has approved an agreement pursuant to which Valneva would supply up to 60 million doses of VLA2001, its inactivated COVID-19...
Mandatory COVID vaccination for all health and social care workers
New measures announced by the Government mean that all health and social care workers, including volunteers who have face to face contact with service...
SMC accepts bimekizumab as treatment for plaque psoriasis
The Scottish Medicines Consortium (SMC) has accepted BIMZELX®▼ (bimekizumab) for use by NHS Scotland as a treatment option for adults with moderate to severe...
Pfizer’s COVID-19 antiviral treatment reduces hospitalisation and death risk by 89%
Pfizer have announced that its investigational novel COVID-19 oral antiviral candidate PAXLOVID™, significantly reduced hospitalization and death, based on an interim analysis of the...
NICE issues draft recommendation for Forxiga to treat kidney disease
The National Institute for Health and Care Excellence (NICE) has issued an Appraisal Consultation Document (ACD) for AstraZeneca’s Forxiga (dapagliflozin) within its marketing authorisation...
Latest articles
NICE recommends Tagrisso for patients with early-stage lung cancer
Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
JCVI responds to Omicron variant and updates its guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
EC grants marketing authorisation for breast cancer treatment Trodelvy
The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
JCVI responds to Omicron variant and updates its guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
NICE recommends Tagrisso for patients with early-stage lung cancer
Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
Sales excellence within a value-based promotional model
Forward thinking brand teams are developing a value-based promotional model to promote products in a way which is perceived as offering real differentiation In 2006,...